TY - JOUR
T1 - Comparative Complications Associated With BMP Use In Patients Undergoing ACDF for Degenerative Spinal Conditions
T2 - Systematic Review and Meta-Analysis
AU - Martin, Christopher T.
AU - Holton, Kenneth
AU - Broida, Samuel E.
AU - Hickmann, Anne Katrin
AU - Bakker, Caitlin
AU - Lender, Paul A.
AU - Watanabe, Kota
AU - Meisel, Hans Jörg
AU - Buser, Zorica
AU - Presciutti, Steven M.
AU - Yoon, Sangwook Tim
N1 - Publisher Copyright:
© The Author(s) 2023.
PY - 2024/2
Y1 - 2024/2
N2 - Study Design: Systematic Review and Meta-Analysis. Objectives: To compare complication incidence in patients with or without the use of recombinant human Bone Morphogenic Protein-2 (BMP2) undergoing anterior cervical discectomy and fusion (ACDF) for degenerative conditions. Methods: A systematic search of eight online databases was conducted using PRISMA guidelines. Inclusion criteria included English language studies with a minimum of 10 adult patients undergoing instrumented ACDF surgery for a degenerative spinal condition in which BMP2 was used in all patients or one of the treatment arms. Studies with patients undergoing circumferential fusions, with non-degenerative indications, or which did not report post-operative complication data were excluded. Patients with and without BMP2 were compared in terms of the incidence of dysphagia/dysphonia, anterior soft tissue complications (hematoma, seroma, infection, dysphagia/dysphonia), nonunion, medical complications, and new neurologic deficits. Results: Of 1832 preliminary search results, 27 manuscripts were included. Meta-analysis revealed the relative risk of dysphagia or dysphonia (RR = 1.39, CI 95% 1.18 – 1.64, P = <.001), anterior soft tissue complications (RR = 1.43, CI 95% 1.25-1.64, P = <.001), and medical complications (RR = 1.32, CI 95% 1.06-1.66, P =.013) were statistically significant in the BMP2 group while the relative risk of non-union (RR =.5, CI 95%.23 - 1.13, P =.09) trended lower in the BMP2 group. Neurological deficit (RR = 1.06, CI 95%.82-1.37, P =.66), and additional medical complications (RR = 1.53, CI 95%.98-2.38, P =.06) were not found to be statistically different between the groups. Conclusions: This meta-analysis identified a high rate of arthrodesis when BMP2 was used in ACDF, but confirmed increased rates of dysphagia and anterior soft tissue complications. Surgeons may consider reserving BMP2 implementation for cases with a high risk of non-union, and should be aware of the risk of airway compromise.
AB - Study Design: Systematic Review and Meta-Analysis. Objectives: To compare complication incidence in patients with or without the use of recombinant human Bone Morphogenic Protein-2 (BMP2) undergoing anterior cervical discectomy and fusion (ACDF) for degenerative conditions. Methods: A systematic search of eight online databases was conducted using PRISMA guidelines. Inclusion criteria included English language studies with a minimum of 10 adult patients undergoing instrumented ACDF surgery for a degenerative spinal condition in which BMP2 was used in all patients or one of the treatment arms. Studies with patients undergoing circumferential fusions, with non-degenerative indications, or which did not report post-operative complication data were excluded. Patients with and without BMP2 were compared in terms of the incidence of dysphagia/dysphonia, anterior soft tissue complications (hematoma, seroma, infection, dysphagia/dysphonia), nonunion, medical complications, and new neurologic deficits. Results: Of 1832 preliminary search results, 27 manuscripts were included. Meta-analysis revealed the relative risk of dysphagia or dysphonia (RR = 1.39, CI 95% 1.18 – 1.64, P = <.001), anterior soft tissue complications (RR = 1.43, CI 95% 1.25-1.64, P = <.001), and medical complications (RR = 1.32, CI 95% 1.06-1.66, P =.013) were statistically significant in the BMP2 group while the relative risk of non-union (RR =.5, CI 95%.23 - 1.13, P =.09) trended lower in the BMP2 group. Neurological deficit (RR = 1.06, CI 95%.82-1.37, P =.66), and additional medical complications (RR = 1.53, CI 95%.98-2.38, P =.06) were not found to be statistically different between the groups. Conclusions: This meta-analysis identified a high rate of arthrodesis when BMP2 was used in ACDF, but confirmed increased rates of dysphagia and anterior soft tissue complications. Surgeons may consider reserving BMP2 implementation for cases with a high risk of non-union, and should be aware of the risk of airway compromise.
KW - ACDF
KW - BMP
KW - degenerative
UR - http://www.scopus.com/inward/record.url?scp=85186943233&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85186943233&partnerID=8YFLogxK
U2 - 10.1177/21925682231166325
DO - 10.1177/21925682231166325
M3 - Article
C2 - 38421328
AN - SCOPUS:85186943233
SN - 2192-5682
VL - 14
SP - 94S-109S
JO - Global Spine Journal
JF - Global Spine Journal
IS - 2_suppl
ER -